NASDAQ:UTHR - Nasdaq - US91307C1027 - Common Stock - Currency: USD
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) offers growth at a reasonable price, with strong profitability, no debt, and a PEG ratio of 0.68. A solid pick for long-term investors.
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) offers strong profitability, zero debt, and an undervalued stock price, making it a candidate for value investors in the biotech sector.
11 large-cap stocks were worst performers last week: SJM, CHWY, IOT, UTHR, CVNA, APP, UAL, GRAB, EIX, LULU, MBLY. Analysts lower price forecasts.
Insmed Incorporated (NASDAQ:INSM) is among the 13 Biotech Stocks with Huge Upside Potential. Kelly Shi of Jefferies has given Insmed Incorporated (NASDAQ:INSM) a buy recommendation, stating that she is confident in the TPIP treatment’s impending Phase 2 data for pulmonary arterial hypertension. Shi anticipates a substantial decrease in pulmonary vascular resistance, the main outcome of […]
An analyst launched coverage of the biotech stock. An analyst's downbeat new take on Summit Therapeutics (NASDAQ: SMMT) pushed its stock downward on Hump Day. Well before market open that day, Leerink Partners' Daina Graybosch initiated coverage on Summit stock.
Shares look likely to break out at the open after the biotech company unveiled promising results for a pulmonary arterial hypertension treatment.
Netflix stock has been on a roll in 2025, as the company's streaming business is insulated from tariffs.
On its first day of trading on the NYSE, Circle Internet Group soared 168%. Circle is the second-largest stablecoin issuer in the world. Based on future growth projections for the stablecoin industry, Circle could be ready to skyrocket in value.
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: CPRX
Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: CORT
United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other best stocks to buy according to Jim Simons’ Renaissance Technologies. Even after his passing in 2024, billionaire investor and […]
See which three stocks the world's most successful hedge fund, which generated returns of +30% for decades, had the biggest stakes in at the end of 2024.
While the top- and bottom-line numbers for United Therapeutics (UTHR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.